165 related articles for article (PubMed ID: 2863016)
1. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity.
Kopelman PG; Noonan K; Goulton R; Forrest AJ
Clin Endocrinol (Oxf); 1985 Jul; 23(1):87-94. PubMed ID: 2863016
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone response to low dose intravenous injections of growth hormone releasing factor in obese and normal weight women.
Kopelman PG; Noonan K
Clin Endocrinol (Oxf); 1986 Feb; 24(2):157-64. PubMed ID: 2871950
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy.
Grossman A; Lytras N; Savage MO; Wass JA; Coy DH; Rees LH; Jones AE; Besser GM
Br Med J (Clin Res Ed); 1984 Jun; 288(6433):1785-7. PubMed ID: 6234047
[TBL] [Abstract][Full Text] [Related]
4. Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release.
Blacklay A; Grossman A; Ross RJ; Savage MO; Davies PS; Plowman PN; Coy DH; Besser GM
J Endocrinol; 1986 Jan; 108(1):25-9. PubMed ID: 2868066
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone and prolactin secretion in hypophysial stalk-transected pigs as affected by growth hormone and prolactin-releasing and inhibiting factors.
Anderson LL; Ford JJ; Klindt J; Molina JR; Vale WW; Rivier J
Proc Soc Exp Biol Med; 1991 Feb; 196(2):194-202. PubMed ID: 1671298
[TBL] [Abstract][Full Text] [Related]
6. The response of obese subjects to continuous infusion of human pancreatic growth hormone-releasing factor 1-44.
Davies RR; Turner SJ; Cook D; Alberti KG; Johnston DG
Clin Endocrinol (Oxf); 1985 Nov; 23(5):521-5. PubMed ID: 3936648
[TBL] [Abstract][Full Text] [Related]
7. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Cordido F; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the hypothalamo-pituitary-IGF-I axis in rats made obese by overfeeding.
Cattaneo L; De Gennaro Colonna V; Zoli M; Müller E; Cocchi D
J Endocrinol; 1996 Feb; 148(2):347-53. PubMed ID: 8699149
[TBL] [Abstract][Full Text] [Related]
9. Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient rats.
Clark RG; Robinson IC
Nature; 1985 Mar 21-27; 314(6008):281-3. PubMed ID: 2858818
[TBL] [Abstract][Full Text] [Related]
10. Additive effects of growth hormone releasing factor and insulin hypoglycaemia on growth hormone release in man.
Page MD; Koppeschaar HP; Edwards CA; Dieguez C; Scanlon MF
Clin Endocrinol (Oxf); 1987 May; 26(5):589-95. PubMed ID: 3117447
[TBL] [Abstract][Full Text] [Related]
11. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
12. Effects of intranasal calcitonin administration on pituitary GH response to hGHRH (1-29)NH2 in normal adult subjects.
Giustina A; Romanelli G; Doga M; Pizzocolo G; Giustina G
Clin Endocrinol (Oxf); 1989 Jun; 30(6):699-704. PubMed ID: 2556224
[TBL] [Abstract][Full Text] [Related]
13. A divergence of plasma growth hormone response between growth hormone-releasing factor and insulin-induced hypoglycaemia among middle-aged healthy male subjects.
Wakabayashi I; Shibasaki T; Ling N
Clin Endocrinol (Oxf); 1986 Mar; 24(3):279-83. PubMed ID: 3085999
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
[TBL] [Abstract][Full Text] [Related]
15. Influence of dopaminergic, adrenergic and cholinergic blockade and TRH administration on GH responses to GRF 1-29.
Jordan V; Dieguez C; Lafaffian I; Rodriguez-Arnao MD; Gomez-Pan A; Hall R; Scanlon MF
Clin Endocrinol (Oxf); 1986 Mar; 24(3):291-8. PubMed ID: 2871952
[TBL] [Abstract][Full Text] [Related]
16. Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man.
Davis JR; Sheppard MC; Shakespear RA; Lynch SS; Clayton RN
Clin Endocrinol (Oxf); 1986 Feb; 24(2):135-40. PubMed ID: 2871948
[TBL] [Abstract][Full Text] [Related]
17. Decreased pituitary growth hormone response to growth hormone-releasing factor in cafeteria-fed rats: dietary and obesity effects.
Renier G; Gaudreau P; Hajjad H; Deslauriers N; Houde-Nadeau M; Brazeau P
Neuroendocrinology; 1990 Sep; 52(3):284-90. PubMed ID: 2145525
[TBL] [Abstract][Full Text] [Related]
18. Pituitary and extrapituitary action sites of the novel nonpeptidyl growth hormone (GH) secretagogue L-692,429 in the chicken.
Geris KL; Hickey GJ; Berghman LR; Visser TJ; Kühn ER; Darras VM
Gen Comp Endocrinol; 1998 Aug; 111(2):186-96. PubMed ID: 9679090
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone response to growth hormone releasing factor in diabetic men.
Kopelman PG; Mason AC; Noonan K; Monson JP
Clin Endocrinol (Oxf); 1988 Jan; 28(1):33-8. PubMed ID: 3139333
[TBL] [Abstract][Full Text] [Related]
20. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
